Between 2013 and 2023, the Italian market for hormones in dosage (except contraceptives and antibiotics) generally expanded, reaching a value of 7.31 billion USD in 2023. Notable growth years were 2014 and 2016, with the highest annual growth recorded in 2016 at 9.31%. The compound annual growth rate (CAGR) over the past five years stood at 1.84%, indicating stable yet modest growth.

Future trends to watch for:

Advancements in medical treatments and new hormone therapies could drive further market growth.
Regulatory changes and health policy shifts might impact market dynamics.
Increasing awareness and demand for hormone-based therapies could stimulate continued market expansion.